The relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's disease

Subscribe to email list

Please select the email list(s) to which you wish to subscribe.

You are here

The relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's disease

TitleThe relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's disease
Publication TypeJournal Article
Year of Publication2000
AuthorsChong, DJ, Suchowersky, O, Szumlanski, C, Weinshilboum, RM, Brant, R, Campbell, NR
JournalClin Neuropharmacol
Volume23
Pagination143–148